Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice
ConclusionThe above results provide evidence for evaluating the immune regulating mechanisms of 4HF in breast cancer and support its clinical significance in its potential as an adjunctive therapeutic agent or immune supplement.
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Allergy & Immunology | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | China Health | Genetics | Herbs | Internal Medicine | Oral Cancer